Biochemical characterisation of amyloid by endomyocardial biopsy

Amyloid

Volumn 16, Issue 1, 2009, Pages 9-14

  Benson, Merrill D ^a,b   Breall, Jeffrey ^c   Cummings, Oscar W ^a   Liepnieks, Juris J ^a  

^a INDIANA UNIVERSITY   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyloid; Amyloidosis; Cardiac biopsy; Cardiomyopathy

Indexed keywords

AMYLOID; CONGO RED; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; BIOPSY; CHEMISTRY; GENETICS; HEART FAILURE; METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; BIOPSY; CARDIOMYOPATHY, RESTRICTIVE; FEMALE; HEART FAILURE; HUMANS; MALE; MONOCLONAL GAMMOPATHIES, BENIGN; PREALBUMIN;

EID: 65449167616     PISSN: 13506129     EISSN: 17442818     Source Type: Journal    
DOI: 10.1080/13506120802676914     Document Type: Article

References (20)

1. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyo-pathy. N Engl J Med 1997;336:267-276.
2. Kyle RA, Gertz MA. Systemic amyloidosis. Crit Rev Oncol Hematol 1990;10:49-87.
3. Benson MD. The hereditary amyloidoses. In: Best practice and research clinical rheumatology. UK: Elsevier; 2003. Vol. 17, Chapter 2, pp 909-927.
4. Kyle RA, Spittell PC, Gertz MA, Li C-Y, Edwards WD, Olson LJ, Thobodeau SN. The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 1996;101:395-400.
5. Ng B, Connors LH, Davidoff R, Skinner M, Falk RH. Senile systemic amyloidosis presenting with heart failure. Arch Intern Med 2005;165:1425-1429.
6. Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, Anderson JJ, O'Hara C, Finn KT, Libbey CA, Wiesman J, Quillen K, Swan W, Wright DG. High-dose Melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med 2004;140:85-93.
7. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002;346:1786-1791.
8. Comenzo RL, Zhou P, Fleisher M, Clark B, Teruya-Feldstein J. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins. Blood 2006;107:3489-3491.
9. Cunningham KS, Veinot JP, Butany J. An approach to endomyocardial biopsy interpretation. J Clin Pathol 2006; 59:121-129.
10. Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid J Protein Folding Dis 2007;14:277-282.
11. Hamidi Asl L, Liepnieks JJ, Hamidi Asl K, Uemichi T, Moulin G, Desjoyaux E, Loire R, Delpech M, Grateau G, Benson MD. Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol 1999;154:221-227.
12. Yazaki M, Liepnieks JJ, Barats MS, Cohen AH, Benson MD. Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 2003;64:11-16.
13. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, Hare JM, Baughman KL, Kasper EK. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol 2004;43:410-415.
14. Sallach JA, Klein AL. Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis. Curr Opin Cardiol 2004;19:464-471.
15. Oki T, Tanaka H, Yamada H, Tabata T, Oishi Y, Ishimoto T, et al. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 2004;93:864-869.
16. Kristen AV, Meyer FJ, Perz JB, Schonland SO, Hundemer M, Hegenbart U, Singer R, Schnabel PA, Sack FU, Goldschmidt H, Katus HA, Dengler TJ. Risk stratification in cardiac amyloidosis: novel approaches. Transplantation 2005;80: S151-S155.
17. Anesi E, Palladini G, Perfetti V, Arbustini E, Obici L, Merlini G. Therapeutic advances demand accurate typing of amyloid deposits. Am J Med 2001;111:243-244.
18. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B, editors. The metabolic and molecular bases of inherited disease. 8th ed. Vol. IV. Chapter 209, Part 22 Connective tissue. New York, NY: McGraw Hill Book Co; 2001. pp 5345-5378.
19. Kingsbury JS, Théberge R, Karbassi JA, Lim A, Costello CE, Connors LH. Detailed structural analysis of amyloido-genic wild-type transthyretin using a novel purification strategy and mass spectrometry. Anal Chem 2007;79:1990-1998.
20. Murphy CL, Wang S, Williams T, Weiss DT, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol 2006;412:48-62.